1. Georges AJ, Leroy EM, Renaut AA,
Tevi Benissan C, Nabias RJ, Trinh Ngoc
M, et al. Ebola hemorrhagic fever out-
breaks in Gabon, 1994–1997: epidemio -
logic and health control issues. J Infect
Dis. 1999;179(Suppl 1):S65–75. DOI:
10.1086/514290
2. Leroy EM, Rouquet P, Formenty P,
Souquière S, Kilbourne A, Froment J-M,
et al. Multiple Ebola virus transmission
events and rapid decline of central African
wildlife. Science. 2004;303:387–90. DOI:
10.1126/science.1092528
3. Walsh PD, Abernethy KA, Bermejo M,
Beyers R, De Wachter P, Ella Akou M,
et al. Catastrophic ape decline in western
equatorial Africa. Nature. 2003;422:611–4.
DOI: 10.1038/nature01566
4. Bermejo M, Rodriguez-Teijeiro JD, Illera
G, Barroso A, Vila C, Walsh PD. Ebola
outbreak killed 5000 gorillas. Science.
2006;314:1564. DOI: 10.1126/science.
1133105
5. Rowe AK, Bertolli J, Khan AS, Makunu
R, Muyembe-Tamfum JJ, Bressler D, et
al. Clinical, virologic, and immunologic
follow-up of convalescent Ebola hemor -
rhagic fever patients and their household
contacts, Kikwit, Democratic Republic of
the Congo. J Infect Dis. 1999;179(Suppl
1):S28–35. DOI: 10.1086/514318
6. Ksiazek TG, Rollin PE, Williams AJ,
Bressler DS, Martin ML, Swanepoel R, et
al. Clinical virology of Ebola hemorrhagic
fever (EHF): virus, virus antigen, and IgG
and IgM antibody findings among EHF
patients in Kikwit, Democratic Republic
of the Congo, 1995. J Infect Dis. 1999;
179(Suppl 1):S177–87. DOI: 10.1086/
514321
7. Ksiazek TG, West CP, Rollin PE, Jahrling
PB, Peters CJ. ELISA for the detection
of antibodies to Ebola viruses. J Infect
Dis. 1999;179(Suppl 1):S192–8. DOI:
10.1086/514313
8. Heffernan RT, Pambo B, Hatchett RJ,
Leman PA, Swanepoel R, Ryder RW.
Low seroprevalence of IgG antibodies to
Ebola virus in an epidemic zone: Ogooue-
Ivindo region, northeastern Gabon, 1997.
J Infect Dis. 2005;191:964–8. DOI: 10.
1086/427994
9. Bausch DG, Borchert M, Grein T, Roth
C, Swanepoel R, Libande ML, et al. Risk
factors for Marburg hemorrhagic fever,
Democratic Republic of the Congo. Emerg
Infect Dis. 2003;9:1531–7.
10. Borchert M, Mulangu S, Swanepoel
R, Tshomba A, Afounde A, Kulidri A,
et al. Pygmy populations seronegative
for Marburg virus. Emerg Infect Dis.
2005;11:174–7.
Address for correspondence: Eric M. Leroy,
Centre International de Recherches Médicales
de Franceville, BP 769, Franceville, Gabon;
email:
[email protected]
Varibaculum
cambriense
Infections in Hong
Kong, China, 2006
To the Editor: Varibaculum cam-
briense is an anaerobic, gram-posi-
tive, diphtheroid bacterium that was
described by Hall et al. in 2003 (1).
Biochemical testing, electrophoretic
analysis of whole-cell proteins, and
phylogenetic analysis of 16S rRNA
gene sequences showed that V. cam-
briense is related to but distinct from
Actinomyces spp. and related taxa,
including the genera Actinobaculum,
Arcanobacterium, and Mobiluncus.
Although its natural habitat re-
mains unknown, V. cambriense has
been isolated from intrauterine de-
vices and human vagina and abscess
specimens (2). Commercial systems,
such as analytical profile index (API)
Rapid ID 32 Strep and Coryne kits
(bioMérieux, Marcy l’Etoile, France),
used in differentiation of novel bacte -
ria provide biochemical profiles useful
for identification of V. cambriense (1).
However, the absence of data on this
organism in manufacturers’ databases
has hampered recognition of V. cam-
briense in routine clinical laboratories.
We report 4 cases of V. cambriense in-
fection and show that this bacterium is
a potential pathogen in skin and soft
tissue infections.
In 2006, four isolates of gram-
positive curved bacilli that grew on
Columbia agar with 5% horse blood
under anaerobic conditions were re-
ferred by 2 regional hospitals in Hong
Kong to our laboratory for identifica -
tion. These isolates originated from
the abscess specimens of 4 patients.
Patient 1 was a 45-year-old wom-
an with a right ovarian chocolate cyst
and endometriosis who had undergone
laparotomy, right salpingo-oophorec -
tomy, and lysis of adhesions in 2001.
Since then, she had a recurrent abscess
over the umbilical scar that was treat -
ed conservatively. Culture of pus from
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 7, July 2009 1137
1These authors contributed equally to this
article.
All material published in Emerging
Infectious Diseases is in the public
domain and may be used and reprinted
without special permission; proper
citation, however, is required.
LETTERS
the umbilical scar grew an unidenti -
fied gram-positive bacillus (M124).
Histologic analysis of umbilical tissue
showed acute suppurative inflamma -
tory cells and microabscess formation.
The patient refused follow-up and
no antimicrobial drug treatment was
given.
Patient 2 was a 25-year-old man
who had a history of excision of mul-
tiple sebaceous cysts in the groin, and
buttock pain and swelling for 4 days.
He had no previous trauma and was
afebrile. An abscess was incised and
drained. Culture of tissue obtained
grew an unidentified gram-positive ba-
cillus (M397) and a Peptostreptococ-
cus spp. The infection later subsided
without antimicrobial drug treatment.
Patient 3 was a 34-year-old man
with a lump in the left groin that had
been present for 1 year. He was hos-
pitalized with erythema and increased
swelling of the lesion. An abscess was
diagnosed, incised, and drained. Gram
staining of pus showed numerous
leukocytes and gram-positive bacilli.
Culture yielded an unidentified gram-
positive bacillus (M380). He was
treated with ampicillin and cloxacillin,
and the wound healed.
Patient 4 was a 55-year-old wom-
an with an abscess on her back. She
had a 3-year history of seronegative
rheumatoid arthritis but was not re-
ceiving immunosuppressant therapy.
The abscess was drained, and gram
staining of pus showed numerous leu-
kocytes and gram-positive cocci and
bacilli. Culture yielded Peptostrepto-
coccus spp. and an unidentified gram-
positive bacillus (M398). The abscess
healed without antimicrobial drug
treatment.
The 4 unidentified gram-positive
bacilli from these patients were ini-
tially characterized by using the API
Rapid ID 32 Strep and Coryne kits.
Doubtful identifications at various
confidence levels were obtained, in-
cluding Corynebacterium diphtheriae
var. mitis or var. belfanti, Gardner-
ella vaginalis, Streptococcus mitis,
S. oralis, Gemella morbillorum, and
Aerococcus urinae. Sequencing of full
length 16S rRNA genes suggested that
the isolates were V. cambriense; Gen-
Bank BLAST (http://blast.ncbi.nlm.
nih.gov/Blast.cgi) results showed V.
cambriense type strain CCUG 44998
T
sequence as the best match (identities
98%–99%) (3).
Biochemical reactions of the
strains were similar to those of CCUG
44998
T (1). All 4 isolates grew poorly
in air and 5% CO2, were catalase nega-
tive, did not hydrolyse esculin or gela-
tin, or reduce nitrates. The 4 isolates
did not ferment most of the carbo-
1138 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 7, July 2009
Table. Characteristics and test results for 4 isolates of unknown bacteria, Hong Kong, China, 2006*
Isolate
Characteristic
Varibaculum
cambriense type
strain CCUG 44998
T
M124 M397 M380 M398
Hospital B B A A
Patient sex/age, y F/45 M/25 M/34 F/55
Date referred/isolated 2006 May 2006 Dec 2006 Dec 2006 Dec
API test code
Rapid ID32 Strep 00100010100 00102010100 02122001100 00002011100
Coryne 1010321 1410321 1010721 1010321
Acid production from
Glucose + + + + +
Lactose – – – – –
Maltose V – (+) – (+) + +
Melibiose – – – – –
Pullulan – – – – –
Raffinose – – – – –
Ribose V + + + – (+)
Sucrose V + + + +
Trehalose V – – + –
MBDG – – – – –
Hydrolysis of hippurate V + + – +
Production of
Į-galactosidase – – – + –
ȕ-galactosidase V – – (+) – –
Į-glucosidase + – (+) – (+) – (+) – (+)
Alkaline phosphatase – – – – –
APPA V – + + +
GenBank accession no.† FJ169866 FJ169867 FJ169868 FJ169869
Identity to type strain CCUG 44998
T
, % 99 98 99 99
*API, analytical profile index; V, variable; MBDG, methyl-ȕ-D-glucopyranoside; APPA, alanyl-phenylalanyl-proline arylamidase. Test